Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, has been named to Fast Company’s inaugural Next Big Things in Tech 2021 honoring the technology breakthroughs that promise to shape the future of their industries—from healthcare to agriculture to artificial intelligence and more.
Earlier this year, Jennifer Ernst, CEO of Tivic Health, was selected as one of Inc’s Female Founders 100 featuring the most inspiring women of the year. The list honors founders who are transforming major industries across the U.S. with world-changing ideas.
“Our team is honored to be named to Fast Company’s Next Big Things in Tech for bringing our first FDA-cleared bioelectronic product, ClearUP® Sinus Pain Relief, to the home market to relieve symptoms of nasal and sinus inflammation from conditions such as nasal allergies, chronic sinusitis, and colds and flu,” said Jennifer Ernst. “The field of bioelectronic medicine is transforming treatment options for numerous conditions, creating a new sector of the therapeutics industry.
“It is a privilege to be included in Inc’s Female Founders that honors a diverse and distinguished group of entrepreneurs,” continued Ernst. “We are leveraging our core technology to provide consumers with modern, well-designed, safe and effective medical devices that improve their quality of life.”
“Fast Company is thrilled to highlight cutting-edge technologies that are solving real-world problems in unexpected ways. From climate change and public health crises to machine learning and security, these technologies will certainly have a profound impact on the future, and we’re honored to bring attention to them today,” said Stephanie Mehta, editor-in-chief, Fast Company.
“The 100 women highlighted on this list are inspiring, creative, tenacious, and trailblazing role models in entrepreneurship. What’s more is they were able to achieve success during one of the toughest years ever. That’s something certainly worth celebrating,” said Scott Omelianuk, editor-in-chief, Inc.
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Stephanie Mehta. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at www.fastcompany.com.
The world’s most trusted business-media brand, Inc., offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning, multiplatform content reaches more than 50 million people each month across a variety of channels, including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion among the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.
About Tivic Health Systems, Inc.
Tivic Health Systems, Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions that treat disease, increase wellness and improve lives. The company develops non-invasive products that offer consumers choice in the treatment of inflammation and related conditions. For more information visit https://tivichealth.com @TivicHealth
Forward Looking Statements
This press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Additional information concerning Tivic Health and its business, including a discussion of factors that could materially affect the company operating results, are contained in the company’s Registration Statement on Form S-1 (and amendments thereto) under the heading “Risk Factors,” as well as the Company’s subsequent filings with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required under applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005278/en/